Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.

Volpe M, Christian Rump L, Ammentorp B, Laeis P.

Clin Drug Investig. 2012 Oct 1;32(10):649-64. doi: 10.2165/11636320-000000000-00000.

PMID:
22909147
2.

Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.

Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.

Hypertension. 2009 Jul;54(1):32-9. doi: 10.1161/HYPERTENSIONAHA.109.131300. Epub 2009 May 26.

3.

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Barrios V, Brommer P, Haag U, Calderón A, Escobar C.

Clin Drug Investig. 2009;29(7):427-39. doi: 10.2165/00044011-200929070-00001.

PMID:
19499960
4.

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.

Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL.

Hypertension. 2007 May;49(5):1047-55. Epub 2007 Mar 12.

6.

Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.

Na SH, Lee HY, Hong Baek S, Jeon HK, Kang JH, Kim YN, Park CG, Ryu JK, Rhee MY, Kim MH, Hong TJ, Choi DJ, Cho SW, Cha DH, Jeon ES, Kim JJ, Shin JH, Park SH, Lee SH, John SH, Shin ES, Kim NH, Lee SY, Kwan J, Jeong MH, Kim SW, Jeong JO, Kim DW, Lee NH, Park WJ, Ahn JC, Won KH, Uk Lee S, Cho JH, Kim SK, Ahn T, Hong S, Yoo SY, Kim SY, Kim BS, Juhn JH, Kim SY, Lee YJ, Oh BH.

Clin Ther. 2015 Aug;37(8):1726-39. doi: 10.1016/j.clinthera.2015.05.512. Epub 2015 Jul 8.

PMID:
26164786
7.

Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.

Hosaka M, Metoki H, Satoh M, Ohkubo T, Asayama K, Kikuya M, Inoue R, Obara T, Hirose T, Imai Y; J-HOME-CARD Study Group.

Hypertens Res. 2015 Oct;38(10):701-7. doi: 10.1038/hr.2015.64. Epub 2015 Jun 4.

PMID:
26041602
8.
9.

Effects of losartan on a background of hydrochlorothiazide in patients with hypertension.

Soffer BA, Wright JT Jr, Pratt JH, Wiens B, Goldberg AI, Sweet CS.

Hypertension. 1995 Jul;26(1):112-7.

10.

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial.

MacDonald TM, Williams B, Caulfield M, Cruickshank JK, McInnes G, Sever P, Webb DJ, Mackenzie IS, Salsbury J, Morant S, Ford I, Brown MJ.

BMJ Open. 2015 Aug 7;5(8):e007645. doi: 10.1136/bmjopen-2015-007645.

11.

A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension.

Hazan L, Hernández Rodriguez OA, Bhorat AE, Miyazaki K, Tao B, Heyrman R; Assessment of Efficacy and Safety of Olmesartan in Pediatric Hypertension Study Group.

Hypertension. 2010 Jun;55(6):1323-30. doi: 10.1161/HYPERTENSIONAHA.109.147702. Epub 2010 Apr 12.

12.

Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure.

Gottwald-Hostalek U, Li L, Montenegro P.

Curr Med Res Opin. 2016 Jul 4:1-9. [Epub ahead of print]

PMID:
27334671
13.

Irbesartan reduces QT dispersion in hypertensive individuals.

Lim PO, Nys M, Naas AA, Struthers AD, Osbakken M, MacDonald TM.

Hypertension. 1999 Feb;33(2):713-8.

14.

Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension.

Brown MJ, Williams B, MacDonald TM, Caulfield M, Cruickshank JK, McInnes G, Sever P, Webb DJ, Salsbury J, Morant S, Ford I.

BMJ Open. 2015 Aug 7;5(8):e008086. doi: 10.1136/bmjopen-2015-008086.

15.

Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients.

Fernández M, Madero R, González D, Camacho P, Villalpando J, Arriaga J.

Hypertension. 1994 Jan;23(1 Suppl):I207-10.

PMID:
8282360
16.

A double-blind, placebo-controlled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension.

Stears AJ, Woods SH, Watts MM, Burton TJ, Graggaber J, Mir FA, Brown MJ.

Hypertension. 2012 May;59(5):934-42. doi: 10.1161/HYPERTENSIONAHA.111.189381. Epub 2012 Apr 9.

17.

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ.

Hypertension. 1997 Jan;29(1 Pt 1):8-14.

18.

If I had resistant hypertension.

O'Brien E.

Hypertension. 2014 Nov;64(5):e3-6. doi: 10.1161/HYPERTENSIONAHA.114.04158. Epub 2014 Aug 11. No abstract available.

19.

Blood pressure lowering effect of Korea ginseng derived ginseol K-g1.

Rhee MY, Cho B, Kim KI, Kim J, Kim MK, Lee EK, Kim HJ, Kim CH.

Am J Chin Med. 2014;42(3):605-18. doi: 10.1142/S0192415X14500396.

PMID:
24871654
20.

Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome.

Laurent S, Boutouyrie P; Vascular Mechanism Collaboration.

Hypertension. 2014 Oct;64(4):709-16. doi: 10.1161/HYPERTENSIONAHA.114.03282. Epub 2014 Jul 7.

Items per page

Supplemental Content

Write to the Help Desk